FORT LEE, N.J., Feb. 21 /PRNewswire-FirstCall/ -- Alpharma Inc. announced that the company will release its fourth quarter 2006 earnings after the market close on Tuesday, February 27, 2007. Alpharma management, will conduct a conference call / webcast on Wednesday, February 28, 2007 beginning at 8:00 AM Eastern Standard Time to discuss its fourth quarter results.
The call will be open to all interested parties and may be accessed by using the following information:
CONFERENCE CALL ACCESS Domestic Dial In: (800) 374-0147 International Dial In: (706) 634-5431 Conference Call ID: 9049436
Investors can access the call in a “listen only” mode via the Internet at http://www.streetevents.com.
In addition, for those unable to participate at the time of the call, a rebroadcast will be available following the call from Wednesday, February 28, 2007 at 12:00 PM Eastern Standard Time until Wednesday, March 7, 2007 at midnight. The rebroadcast may be accessed on the Internet at http://www.streetevents.com or by telephone using the following information:
REBROADCAST ACCESS Domestic Dial In: (800) 642-1687 International Dial In: (706) 645-9291 Participant Code: 9049436
Alpharma Inc. is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world’s leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.
Alpharma Inc.
CONTACT: Kathleen Makrakis, VP, Investor Relations, +1-201-228-5085,kathleen.makrakis@alpharma.com
Web site: http://www.alpharma.com/
